Concepts (122)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Skin Neoplasms | 9 | 2024 | 4655 | 0.580 |
Why?
|
| Indoles | 3 | 2014 | 1011 | 0.470 |
Why?
|
| Merkel cell polyomavirus | 1 | 2012 | 30 | 0.420 |
Why?
|
| Carcinoma, Merkel Cell | 1 | 2012 | 155 | 0.370 |
Why?
|
| Sulfonamides | 3 | 2014 | 1826 | 0.370 |
Why?
|
| Pyoderma Gangrenosum | 1 | 2010 | 5 | 0.360 |
Why?
|
| Dapsone | 1 | 2010 | 16 | 0.360 |
Why?
|
| DNA, Viral | 1 | 2012 | 675 | 0.350 |
Why?
|
| Drug Eruptions | 1 | 2012 | 258 | 0.350 |
Why?
|
| Skin | 4 | 2018 | 1260 | 0.320 |
Why?
|
| Tacrolimus | 1 | 2010 | 342 | 0.310 |
Why?
|
| Melanocytes | 2 | 2021 | 220 | 0.310 |
Why?
|
| Carcinoma, Squamous Cell | 4 | 2024 | 5435 | 0.300 |
Why?
|
| Skin Diseases | 3 | 2018 | 351 | 0.290 |
Why?
|
| Prednisone | 1 | 2010 | 983 | 0.290 |
Why?
|
| Biopsy | 7 | 2021 | 3448 | 0.230 |
Why?
|
| Hypopigmentation | 2 | 2012 | 28 | 0.210 |
Why?
|
| Nails | 1 | 2021 | 35 | 0.200 |
Why?
|
| Hamartoma | 2 | 2012 | 115 | 0.190 |
Why?
|
| Melanoma | 5 | 2021 | 5319 | 0.190 |
Why?
|
| Anti-Bacterial Agents | 1 | 2012 | 2992 | 0.170 |
Why?
|
| Psoriasis | 1 | 2019 | 127 | 0.160 |
Why?
|
| Proto-Oncogene Proteins B-raf | 2 | 2015 | 1284 | 0.150 |
Why?
|
| Computers, Handheld | 1 | 2018 | 69 | 0.150 |
Why?
|
| Photography | 1 | 2018 | 138 | 0.150 |
Why?
|
| MAP Kinase Kinase 4 | 2 | 2013 | 142 | 0.140 |
Why?
|
| Electric Stimulation | 1 | 2016 | 427 | 0.120 |
Why?
|
| Foot Dermatoses | 1 | 2014 | 23 | 0.120 |
Why?
|
| Connectome | 1 | 2016 | 115 | 0.120 |
Why?
|
| Sweet Syndrome | 1 | 2014 | 36 | 0.120 |
Why?
|
| Cyclin D1 | 1 | 2015 | 577 | 0.110 |
Why?
|
| Oximes | 1 | 2013 | 176 | 0.110 |
Why?
|
| Diagnosis, Differential | 2 | 2013 | 4745 | 0.110 |
Why?
|
| Keratosis, Actinic | 1 | 2012 | 37 | 0.100 |
Why?
|
| Stevens-Johnson Syndrome | 1 | 2012 | 21 | 0.100 |
Why?
|
| Niacinamide | 1 | 2013 | 421 | 0.100 |
Why?
|
| Cerebral Cortex | 1 | 2016 | 624 | 0.100 |
Why?
|
| Cell Proliferation | 3 | 2013 | 7241 | 0.100 |
Why?
|
| Dermatology | 1 | 2012 | 70 | 0.100 |
Why?
|
| Communicable Diseases | 1 | 2013 | 198 | 0.090 |
Why?
|
| Phenylurea Compounds | 1 | 2013 | 581 | 0.090 |
Why?
|
| Photochemotherapy | 1 | 2010 | 97 | 0.090 |
Why?
|
| Carcinoma, Papillary | 1 | 2013 | 586 | 0.090 |
Why?
|
| Exanthema | 1 | 2012 | 210 | 0.090 |
Why?
|
| Protein Kinases | 1 | 2013 | 875 | 0.080 |
Why?
|
| Carcinoma, Basal Cell | 1 | 2012 | 272 | 0.080 |
Why?
|
| Syndrome | 1 | 2012 | 1351 | 0.080 |
Why?
|
| Contraceptives, Oral, Combined | 1 | 2007 | 21 | 0.080 |
Why?
|
| Spironolactone | 1 | 2007 | 22 | 0.080 |
Why?
|
| Imidazoles | 1 | 2013 | 1003 | 0.080 |
Why?
|
| Androstenes | 1 | 2007 | 41 | 0.080 |
Why?
|
| Acne Vulgaris | 1 | 2007 | 47 | 0.080 |
Why?
|
| Hematologic Neoplasms | 1 | 2019 | 1901 | 0.070 |
Why?
|
| Neoplasms, Second Primary | 1 | 2015 | 1350 | 0.070 |
Why?
|
| Middle Aged | 10 | 2021 | 86548 | 0.070 |
Why?
|
| Male | 11 | 2021 | 123347 | 0.070 |
Why?
|
| Humans | 19 | 2024 | 262269 | 0.070 |
Why?
|
| Androgen Receptor Antagonists | 1 | 2007 | 111 | 0.070 |
Why?
|
| Glucocorticoids | 1 | 2010 | 637 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 1 | 2012 | 3189 | 0.070 |
Why?
|
| Anti-Infective Agents | 1 | 2010 | 447 | 0.070 |
Why?
|
| Leukemia | 1 | 2013 | 1633 | 0.060 |
Why?
|
| Drug Therapy, Combination | 1 | 2010 | 2325 | 0.060 |
Why?
|
| Immunosuppressive Agents | 1 | 2010 | 1416 | 0.060 |
Why?
|
| Thyroid Neoplasms | 1 | 2013 | 1868 | 0.050 |
Why?
|
| Lymphatic Metastasis | 1 | 2012 | 4845 | 0.050 |
Why?
|
| Skin Pigmentation | 2 | 2012 | 47 | 0.050 |
Why?
|
| Apoptosis | 2 | 2013 | 7601 | 0.050 |
Why?
|
| Back | 2 | 2012 | 45 | 0.050 |
Why?
|
| Aged | 7 | 2021 | 70370 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2010 | 4945 | 0.050 |
Why?
|
| Lymph Nodes | 1 | 2012 | 2969 | 0.050 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2019 | 6606 | 0.050 |
Why?
|
| Adult | 9 | 2021 | 78181 | 0.050 |
Why?
|
| Follow-Up Studies | 3 | 2010 | 14914 | 0.050 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2015 | 4768 | 0.050 |
Why?
|
| Lymphoma | 1 | 2008 | 1471 | 0.040 |
Why?
|
| Aged, 80 and over | 5 | 2021 | 29996 | 0.040 |
Why?
|
| Immunohistochemistry | 3 | 2015 | 7545 | 0.040 |
Why?
|
| Young Adult | 4 | 2021 | 21493 | 0.040 |
Why?
|
| Predictive Value of Tests | 3 | 2012 | 4903 | 0.040 |
Why?
|
| Female | 10 | 2021 | 142305 | 0.040 |
Why?
|
| Allografts | 1 | 2019 | 656 | 0.040 |
Why?
|
| Immunotherapy | 1 | 2010 | 3347 | 0.040 |
Why?
|
| Prospective Studies | 3 | 2019 | 12923 | 0.040 |
Why?
|
| Documentation | 1 | 2018 | 205 | 0.030 |
Why?
|
| Mutation | 1 | 2015 | 15167 | 0.030 |
Why?
|
| Antineoplastic Agents | 2 | 2015 | 14288 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2013 | 11972 | 0.030 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2016 | 210 | 0.030 |
Why?
|
| Adolescent | 4 | 2021 | 31238 | 0.030 |
Why?
|
| Time Factors | 2 | 2021 | 12985 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2021 | 2236 | 0.030 |
Why?
|
| Neural Pathways | 1 | 2016 | 297 | 0.030 |
Why?
|
| Mice, Hairless | 1 | 2013 | 55 | 0.030 |
Why?
|
| raf Kinases | 1 | 2013 | 81 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2008 | 13669 | 0.030 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2013 | 188 | 0.030 |
Why?
|
| Electroencephalography | 1 | 2016 | 893 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2018 | 2804 | 0.020 |
Why?
|
| Biomarkers | 2 | 2012 | 5055 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2013 | 848 | 0.020 |
Why?
|
| Limb Salvage | 1 | 2010 | 163 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2015 | 2450 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2016 | 1650 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2021 | 6900 | 0.020 |
Why?
|
| Illinois | 1 | 2008 | 24 | 0.020 |
Why?
|
| Ethinyl Estradiol | 1 | 2007 | 16 | 0.020 |
Why?
|
| Epilepsy | 1 | 2016 | 881 | 0.020 |
Why?
|
| Survival Rate | 1 | 2021 | 12239 | 0.020 |
Why?
|
| Child | 2 | 2021 | 29065 | 0.020 |
Why?
|
| Cell Survival | 1 | 2013 | 3042 | 0.020 |
Why?
|
| Sezary Syndrome | 1 | 2008 | 159 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2021 | 38022 | 0.020 |
Why?
|
| Mycosis Fungoides | 1 | 2008 | 320 | 0.020 |
Why?
|
| Risk Factors | 1 | 2021 | 17622 | 0.010 |
Why?
|
| Prognosis | 1 | 2021 | 21737 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2015 | 33028 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2013 | 14561 | 0.010 |
Why?
|
| Mice | 1 | 2013 | 34391 | 0.010 |
Why?
|
| Animals | 1 | 2013 | 59486 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2008 | 15874 | 0.000 |
Why?
|